T. Rowe Price Investment Management, Inc. a Braidwell LP se účastní jako noví investoři. Stephen Williams, MD, Ph.D., nastupuje jako vědecký ředitel. Rebecca Chambersová a Frank Witney, Ph.D., byli jmenováni do představenstva. FREMONT, Kalifornie, 12. ledna 2026 /PRNewswire/ — Společnost Alamar Biosciences, Inc. („Alamar”), vedoucí podnik v oblasti přesné proteomiky zaměřený na pokrok v oblasti… Continue reading Společnost Alamar Biosciences oznamuje, že poptávka investorů po konvertibilních dluhopisech převýšila nabídku a rozšíření vedoucího týmu
Tag: Ford
@niche: AND… WE’RE BACK.004222
Editor’s Note: WE. ARE. BACK. Peter takes us on a trip through the highlights of last year’s On The Table, and shares a few thoughts about the biz as we dive into this New Year. In On The Table, we detail the 2027 Ram 1500 SRT TRX, or, as Peter calls it, “a rolling monument to abject stupidity.” We also have… Continue reading @niche: AND… WE’RE BACK.004222
Ford CEO Jim Hackett On Human Centered Design And Unleashing Talent – Forbes
Ford CEO Jim Hackett On Human Centered Design And Unleashing Talent Forbes Go to Source
Ford CEO Jim Hackett has finally come into his own as the carmaker launches its much-anticipated Bronco SUV – Business Insider
Ford CEO Jim Hackett has finally come into his own as the carmaker launches its much-anticipated Bronco SUV Business Insider Go to Source
Bill Ford on CEO Hackett: ‘I love having him here’ – Detroit Free Press
Bill Ford on CEO Hackett: ‘I love having him here’ Detroit Free Press Go to Source
Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt
T. Rowe Price Investment Management, Inc. und Braidwell LP beteiligen sich als neue Investoren Stephen Williams, MD, Ph.D. tritt als wissenschaftlicher Leiter ein Rebecca Chambers und Frank Witney, Ph.D., in den Verwaltungsrat berufen FREMONT, Kalifornien, 12.Januar 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), , ein führendes Unternehmen im Bereich der Präzisionsproteomik, das sich der Früherkennung von Krankheiten… Continue reading Alamar Biosciences gibt Abschluss der überzeichneten Wandelanleihe-Finanzierung und Erweiterung des Führungsteams bekannt
Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
SHANGHAI and BOSTON, Jan. 11, 2026 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced that Dr. Dongxu Shu, Co-Founder, Chairman of the Board, and Chief Executive Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on Thursday, January 15th 2026 at… Continue reading Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Alamar Biosciences annonce la clôture d’un financement par billets convertibles sursouscrits et l’élargissement de l’équipe de direction
T. Rowe Price Investment Management, Inc. et Braidwell LP sont de nouveaux investisseurs. Stephen Williams, MD, Ph.D., devient directeur scientifique. Rebecca Chambers et Frank Witney, Ph.D., nommés au conseil d’administration FREMONT, Calif., 12 janvier 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), un leader de la protéomique de précision qui se consacre à la détection précoce des maladies,… Continue reading Alamar Biosciences annonce la clôture d’un financement par billets convertibles sursouscrits et l’élargissement de l’équipe de direction
Inside GM’s new world headquarters: Modernized midcentury designs with artifacts, surprises from the American icon
A 1963 Chevrolet K20 pickup truck and a new Chevrolet Silverado EV sit outside General Motors’ new world headquarters on Jan. 6, 2026 in Detroit. Michael Wayland | CNBC DETROIT – Outside General Motors‘ new world headquarters, between the 12-story building and the city’s first new skyscraper in more than 30 years, sit two red… Continue reading Inside GM’s new world headquarters: Modernized midcentury designs with artifacts, surprises from the American icon
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors FREMONT, Calif., Jan. 11, 2026 /PRNewswire/ — Alamar Biosciences, Inc. (“Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease,… Continue reading Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team